Teva Pharmaceutical Industries

NYSE:TEVA Stock Report

Mkt Cap: US$9.6b

Teva Pharmaceutical Industries Past Performance

How has Teva Pharmaceutical Industries performed over the past 5 years?

[object Object] Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


50.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: TEVA is currently unprofitable.

Growing Profit Margin: TEVA is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: TEVA is unprofitable, but has reduced losses over the past 5 years at a rate of 50.9% per year.

Accelerating Growth: Unable to compare TEVA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TEVA is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (8.4%).


Return on Equity

High ROE: TEVA has a negative Return on Equity (-13.71%), as it is currently unprofitable.


Discover strong past performing companies